Expert Review of Clinical Immunology
Volume 18, 2022 - Issue 4
Review
Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives
Frederik Flindt Kreinera Global Chief Medical Office, Novo Nordisk A/S, Søborg, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0001-8296-453XView further author information
https://orcid.org/0000-0001-8296-453XView further author information, Jordan M Kraaijenhofa Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark;b Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlandshttps://orcid.org/0000-0001-7566-6403View further author information
https://orcid.org/0000-0001-7566-6403View further author information, Matthias von Herratha Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark;c Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USAhttps://orcid.org/0000-0002-5211-0485View further author information
https://orcid.org/0000-0002-5211-0485View further author information, G. Kees Kornelis Hovingha Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark;b Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlandshttps://orcid.org/0000-0002-8145-1676View further author information
https://orcid.org/0000-0002-8145-1676View further author information & Bernt Johan von Scholtena Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmarkhttps://orcid.org/0000-0002-1489-0636View further author information
https://orcid.org/0000-0002-1489-0636View further author information